These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 443682)

  • 21. Ineffectiveness of historical data in predicting measles susceptibility.
    Scott RM; Butler AB; Schydlower M; Rawlings P
    Pediatrics; 1984 Jun; 73(6):777-80. PubMed ID: 6728580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of viral specific CD4 T cells to in vitro stimulation with vaccine and wild measles virus strains in vaccinated and naturally infected subjects.
    Cześcik A; Dunal-Szczepaniak M; Trzcińska A; Siennicka J
    Pol J Microbiol; 2014; 63(2):203-9. PubMed ID: 25115114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles: lessons from an outbreak.
    Gurevich I; Barzarga RA; Cunha BA
    Am J Infect Control; 1992 Dec; 20(6):319-25. PubMed ID: 1492697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low antibody response in infants with measles and children with subclinical measles virus infection.
    Cherian T; Joseph A; John TJ
    J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuing measles transmission in students despite school-based outbreak control program.
    Wassilak SG; Orenstein WA; Strickland PL; Butler CA; Bart KJ
    Am J Epidemiol; 1985 Aug; 122(2):208-17. PubMed ID: 4014205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles Virus Is Unforgiving Where Immunity Gaps Exist.
    Durrheim DN
    J Infect Dis; 2017 Dec; 216(10):1183-1184. PubMed ID: 29040599
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.
    Whittle HC; Aaby P; Samb B; Jensen H; Bennett J; Simondon F
    Lancet; 1999 Jan; 353(9147):98-102. PubMed ID: 10023894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
    Hickman CJ; Hyde TB; Sowers SB; Mercader S; McGrew M; Williams NJ; Beeler JA; Audet S; Kiehl B; Nandy R; Tamin A; Bellini WJ
    J Infect Dis; 2011 Jul; 204 Suppl 1():S549-58. PubMed ID: 21666212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G; Boulianne N; Ratnam S; Corriveau A
    Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A measles outbreak at a college with a prematriculation immunization requirement.
    Hersh BS; Markowitz LE; Hoffman RE; Hoff DR; Doran MJ; Fleishman JC; Preblud SR; Orenstein WA
    Am J Public Health; 1991 Mar; 81(3):360-4. PubMed ID: 1994745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.
    Parker AA; Staggs W; Dayan GH; Ortega-Sánchez IR; Rota PA; Lowe L; Boardman P; Teclaw R; Graves C; LeBaron CW
    N Engl J Med; 2006 Aug; 355(5):447-55. PubMed ID: 16885548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015.
    Tang L; Zhou Y; Pan Y; Zhu H
    Vaccine; 2017 May; 35(22):2925-2929. PubMed ID: 28433329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.
    Smetana J; Chlibek R; Hanovcova I; Sosovickova R; Smetanova L; Gal P; Dite P
    PLoS One; 2017; 12(1):e0170257. PubMed ID: 28085960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies.
    Cutts FT; Bartoloni A; Guglielmetti P; Gil F; Brown D; Bianchi Bandinelli ML; Roselli M
    Trans R Soc Trop Med Hyg; 1995; 89(1):119-22. PubMed ID: 7747295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measles in adults in the XXI century].
    Muñoz-Sanz A; Rodríguez-Vidigal FF; Nogales-Muñoz N; Vera-Tomé A
    Med Clin (Barc); 2013 Jun; 140(12):567-8. PubMed ID: 23245535
    [No Abstract]   [Full Text] [Related]  

  • 36. Measles seroprevalence and vaccine response in HIV-infected adults.
    Wallace MR; Hooper DG; Graves SJ; Malone JL
    Vaccine; 1994 Oct; 12(13):1222-4. PubMed ID: 7839728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults.
    Sha BE; Harris AA; Benson CA; Atkinson WL; Urbanski PA; Stewart JA; Williams WW; Murphy RL; Phair JP; Levin SA
    J Infect Dis; 1991 Nov; 164(5):973-5. PubMed ID: 1682395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.
    Edmonson MB; Addiss DG; McPherson JT; Berg JL; Circo SR; Davis JP
    JAMA; 1990 May; 263(18):2467-71. PubMed ID: 2278542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of a measles epidemic; possible role of vaccine failures.
    Rawls WE; Rawls ML; Chernesky MA
    Can Med Assoc J; 1975 Nov; 113(10):941-4. PubMed ID: 1192310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.